Cardiology: Lessons of clinical cardiological research;Kardiologie: Lehren aus der klinisch-kardiologischen forschung

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 51-52, 1999, Pages 1556-1558

  Erdmann, Erland ^a  

^a M K III der M E der U zu K   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLOSEQUINAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIBEFRADIL; MINOXIDIL; PIMOBENDAN; PIPERANOMETOZINE; XAMOTEROL;

ANTIHYPERTENSIVE THERAPY; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL RESEARCH; DRUG EFFICACY; DRUG INDICATION; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; REVIEW;

CARDIOLOGY; DIAGNOSTIC IMAGING; FORECASTING; HEART DISEASES; HUMANS; MULTICENTER STUDIES; MYOCARDIAL REVASCULARIZATION; PILOT PROJECTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH;

EID: 0033598960     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. 1 Massie, B.: 15 years of heart-failure trials: what have we learned? Lancet 352 (1998), 29-33
2. 2 World Health Organization - International Society of Hypertension 1999: Guidelines for the management of hypertension. J Hypertens 17 (1999), 151-83
3. 3 Sever, E. et al.: Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Brit Med J 306 (1993), 983-7
4. 4 Yee, K., Struthers, A.: Can drug effects on mortality in heart failure be predicted by any surrogate measure? Europ Heart J 18 (1997), 1860-4
5. 5 Yusuf, S.: Calcium antagonists in coronary artery disease and hypertension. Circulation 92 (1995), 1079-82
6. 6 Siegel, D., Lopez, J.: Trends in antihypertensive drug use in the United States. J Amer Med Ass 278 (1997), 1745-8
7. 7 The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 353 (1999), 9-13
8. 8 Echt, D. et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 324 (1991), 781-8
9. 9 Schoffield, P. et al.: Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 353 (1999), 519-524.